| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8962253 | Cytotherapy | 2018 | 12 Pages |
Abstract
We conclude that CB-CIKs, combined with bispecific T-cell-engaging antibodies, offer a novel, effective treatment strategy for leukemia.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cell Biology
Authors
JOSÃE GOLAY, SIMONA MARTINELLI, RACHELE ALZANI, SABRINA CRIBIOLI, CLARA ALBANESE, ELISA GOTTI, BRUNA PASINI, BENEDETTA MAZZANTI, RICCARDO SACCARDI, ALESSANDRO RAMBALDI, MARTINO INTRONA,